Brief: Achilles Therapeutics Receives Approval To Transfer To Nasdaq Capital Market
19/11/2024 12:04
Nov 19 (Reuters) - Achilles Therapeutics PLC 698y.F :
* ACHILLES THERAPEUTICS RECEIVES APPROVAL TO TRANSFER TO
NASDAQ
CAPITAL MARKET
* ACHILLES THERAPEUTICS PLC - TRANSFER EFFECTIVE NOVEMBER
19, 2024
Source text: ID:nGNX9BFw7R
Further company coverage: 698y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Achilles Therapeutics
See all newsBrief: Achilles Therapeutics Announces Sale Of Technology Assets To Astrazeneca
Brief: Achilles Therapeutics Receives Approval To Transfer To Nasdaq Capital Market
Achilles gains on plans to explore strategic options
Brief: Achilles Therapeutics To Discontinue Development Of TIL-Based cNET Therapy
Brief: Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement